申请人:Beiersdorf AG
公开号:US04871775A1
公开(公告)日:1989-10-03
New substituted phenoxyalkanolamines and phenoxyalkanol-cycloalkylamines of the general formula I ##STR1## in which R.sup.1 and R.sup.2, which can be identical or different, denote alkyl groups with in each case 1 to 4 carbon atoms, or R.sup.1 and R.sup.2 together denote the group --(CH.sub.2).sub.n --, wherein n is the number 4 or 5, R.sup.3 denotes hydrogen, or an alkyl group or an acyl group with in each case 1 to 6 carbon atoms, R.sub.4 denotes an alkyl group with 1 to 4 carbon atoms or the cyclopropylmethyl group and R.sup.5 denotes hydrogen halogen or alkyl, and acid addiition salts thereof, have a cardioselective .beta..sub.1 -adrenolytic and hypotensive action. They can be used as medicaments for the treatment of angina pectoris, hypertension and arrhythmias.
新的取代的苯氧基丙醇胺和苯氧基丙醇-环烷胺,其一般式为I ##STR1## 其中,R.sup.1和R.sup.2可以相同也可以不同,表示具有1至4个碳原子的烷基,或者R.sup.1和R.sup.2在一起表示--(CH.sub.2).sub.n--,其中n为4或5,R.sup.3表示氢,或者具有1至6个碳原子的烷基或酰基,R.sub.4表示具有1至4个碳原子的烷基或环丙甲基基团,R.sup.5表示氢、卤素或烷基,以及它们的酸加成盐具有心脏选择性的β1-肾上腺素受体拮抗作用和降压作用。它们可用作治疗心绞痛、高血压和心律失常的药物。